Jaguar Health (JAGX) Amortizatization of Intangibles (2014 - 2026)
Jaguar Health (JAGX) reported Amortizatization of Intangibles of $47000.0 for Q1 2026, down 29.85% year-over-year from $67000.0 in Q1 2025, and down 28.79% quarter-over-quarter from $66000.0 in Q4 2025.
Jaguar Health (JAGX) Amortizatization of Intangibles (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 10 years of Amortizatization of Intangibles data on file, last reported at $47000.0 in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $47000.0, down 29.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $269000.0 (down 35.34% YoY), and the FY2025 annual result was $289000.0, down 36.9% from the prior year.
- Amortizatization of Intangibles declined to $47000.0 in Q1 2026 per JAGX's latest filing, from $66000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $122000.0 in Q3 2024 and troughed at $29000.0 in Q1 2022.
- A 5-year average of $87058.8 and a median of $89000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles soared 131.91% in 2024, then tumbled 42.61% in 2025.
- A 5-year view of Amortizatization of Intangibles shows it stood at $103000.0 in 2022, then dropped by 13.59% to $89000.0 in 2023, then gained by 29.21% to $115000.0 in 2024, then plunged by 42.61% to $66000.0 in 2025, then decreased by 28.79% to $47000.0 in 2026.
- Business Quant data shows JAGX's Amortizatization of Intangibles at $47000.0 in Q1 2026, $66000.0 in Q4 2025, and $78000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | 47,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47,000.00 |
| Mar 31, 2026 | 47,000.00 |
| Dec 31, 2025 | 66,000.00 |
| Dec 31, 2025 | 66,000.00 |
| Sep 30, 2025 | 78,000.00 |
| Sep 30, 2025 | 78,000.00 |
| Jun 30, 2025 | 78,000.00 |
| Jun 30, 2025 | 78,000.00 |
| Mar 31, 2025 | 67,000.00 |
| Mar 31, 2025 | 67,000.00 |
| Dec 31, 2024 | 115,000.00 |
| Dec 31, 2024 | 115,000.00 |
| Sep 30, 2024 | 122,000.00 |
| Sep 30, 2024 | 122,000.00 |
| Jun 30, 2024 | 112,000.00 |
| Jun 30, 2024 | 112,000.00 |
| Mar 31, 2024 | 109,000.00 |
| Mar 31, 2024 | 109,000.00 |
| Dec 31, 2023 | 89,000.00 |
| Dec 31, 2023 | 89,000.00 |